The US PLGA market is projected to grow from USD 215 Million in 2020 to USD 545 Million in 2035, highlighting significant expansion driven by adoption in healthcare solutions. The period between 2025-2030 is expected to show the fastest growth due to increased investment and regulatory approvals. Uptake in drug delivery, tissue engineering, and orthopedic solutions is fueling revenue, reflecting strong market confidence in PLGA technology to meet evolving medical demands across patient populations.
Read More - https://bussinessinsights.com/research-report/us-plga-market
The leading application area for PLGA in the US is drug delivery, accounting for 42% of the market in 2025. This is driven by the polymer’s biocompatibility and adoption in tailored, controlled-release medications. Tissue engineering holds a significant share, supported by chronic disease prevalence and advancements in regenerative therapies. Orthopedic implants and dental solutions also see considerable uptake, while wound management marks an emerging niche for growth. Innovations in application and improved clinical outcomes underpin expansion across these segments.
Request Free Sample- https://bussinessinsights.com/request/chemical-and-material/us-plga-market
Who are the key players in US PLGA Market industry?
The top five players in the US PLGA market include Evonik Industries, Corbion, PolySciTech, Shenzhen Jinjiacheng Technology, and Henan Xingfa Bio-Technology. These companies are recognized for their advanced production capacities, strong R&D focus, and provision of high-quality PLGA for medical, pharmaceutical, and industrial applications.
What is the US PLGA Market growth?
The US PLGA market has demonstrated robust growth, driven by rising demand for biodegradable polymers in drug delivery and medical devices. Recently, Evonik Industries expanded its PLGA production to meet increased pharmaceutical sector needs, reflecting a significant market expansion and new application opportunities.
Which segment accounted for the largest US PLGA Market share?
Drug delivery was the largest application segment in the US PLGA market, leveraging the polymer’s biodegradability and controlled-release properties. Pharmaceutical companies favor PLGA for formulating injectable microspheres and implants, improving patient compliance and drug efficacy in chronic disease treatments.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com